King Pfizer Drug Patent Portfolio
King Pfizer owns 1 orange book drug protected by 1 US patent Given below is the list of King Pfizer's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events | 30 Aug, 2020 | Expired |
Latest Legal Activities on King Pfizer's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of King Pfizer.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2019 | US7368469 |
| Post Issue Communication - Certificate of Correction | 25 Jun, 2008 | US7368469 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 May, 2008 | US7368469 |
|
Recordation of Patent Grant Mailed
Critical
| 06 May, 2008 | US7368469 |
|
Issue Notification Mailed
Critical
| 16 Apr, 2008 | US7368469 |
| Dispatch to FDC | 31 Mar, 2008 | US7368469 |
| Mail Miscellaneous Communication to Applicant | 26 Mar, 2008 | US7368469 |
|
Application Is Considered Ready for Issue
Critical
| 26 Mar, 2008 | US7368469 |
| Miscellaneous Communication to Applicant - No Action Count | 20 Mar, 2008 | US7368469 |
|
Issue Fee Payment Verified
Critical
| 29 Feb, 2008 | US7368469 |
|
Issue Fee Payment Received
Critical
| 29 Feb, 2008 | US7368469 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 21 Feb, 2008 | US7368469 |
|
Information Disclosure Statement considered
Critical
| 21 Feb, 2008 | US7368469 |
|
Mail Notice of Allowance
Critical
| 15 Jan, 2008 | US7368469 |
| Mail Examiner's Amendment | 15 Jan, 2008 | US7368469 |
King Pfizer's Family Patents
King Pfizer Drug List
Given below is the complete list of King Pfizer's drugs and the patents protecting them.
1. Altace
Altace is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
30 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Altace's drug page